Promotion of access to essential medicines for Non-Communicable Diseases: Practical implications of the UN Political Declaration

Hdl Handle:
http://hdl.handle.net/10144/279037
Title:
Promotion of access to essential medicines for Non-Communicable Diseases: Practical implications of the UN Political Declaration
Authors:
Hogerzeil, Hans V; Liberman, Jonathan; Wirtz, Veronika J; Kishore, Sandeep P; Selvaraj, Sakthi; Kiddell-Monroe, Rachel; Mwangi-Powell, Faith N; von Schoen-Angerer, Tido
Journal:
Lancet
Abstract:
Access to medicines and vaccines to prevent and treat non-communicable diseases (NCDs) is unacceptably low worldwide. In the 2011 UN political declaration on the prevention and control of NCDs, heads of government made several commitments related to access to essential medicines, technologies, and vaccines for such diseases. 30 years of experience with policies for essential medicines and 10 years of scaling up of HIV treatment have provided the knowledge needed to address barriers to long-term effective treatment and prevention of NCDs. More medicines can be acquired within existing budgets with efficient selection, procurement, and use of generic medicines. Furthermore, low-income and middle-income countries need to increase mobilisation of domestic resources to cater for the many patients with NCDs who do not have access to treatment. Existing initiatives for HIV treatment offer useful lessons that can enhance access to pharmaceutical management of NCDs and improve adherence to long-term treatment of chronic illness; policy makers should also address unacceptable inequities in access to controlled opioid analgesics. In addition to off-patent medicines, governments can promote access to new and future on-patent medicinal products through coherent and equitable health and trade policies, particularly those for intellectual property. Frequent conflicts of interest need to be identified and managed, and indicators and targets for access to NCD medicines should be used to monitor progress. Only with these approaches can a difference be made to the lives of hundreds of millions of current and future patients with NCDs.
Affiliation:
Department of Global Health, University of Groningen, University Medical Centre, Groningen, Netherlands. h.v.hogerzeil@umcg.nl
Issue Date:
12-Feb-2013
URI:
http://hdl.handle.net/10144/279037
DOI:
10.1016/S0140-6736(12)62128-X
PubMed ID:
23410612
Language:
en
ISSN:
1474-547X
Appears in Collections:
Health Politics

Full metadata record

DC FieldValue Language
dc.contributor.authorHogerzeil, Hans Ven_GB
dc.contributor.authorLiberman, Jonathanen_GB
dc.contributor.authorWirtz, Veronika Jen_GB
dc.contributor.authorKishore, Sandeep Pen_GB
dc.contributor.authorSelvaraj, Sakthien_GB
dc.contributor.authorKiddell-Monroe, Rachelen_GB
dc.contributor.authorMwangi-Powell, Faith Nen_GB
dc.contributor.authorvon Schoen-Angerer, Tidoen_GB
dc.date.accessioned2013-04-04T22:59:21Z-
dc.date.available2013-04-04T22:59:21Z-
dc.date.issued2013-02-12-
dc.identifier.citationPromotion of access to essential medicines for non-communicable diseases: practical implications of the UN political declaration. 2013, 381 (9867):680-9 Lanceten_GB
dc.identifier.issn1474-547X-
dc.identifier.pmid23410612-
dc.identifier.doi10.1016/S0140-6736(12)62128-X-
dc.identifier.urihttp://hdl.handle.net/10144/279037-
dc.description.abstractAccess to medicines and vaccines to prevent and treat non-communicable diseases (NCDs) is unacceptably low worldwide. In the 2011 UN political declaration on the prevention and control of NCDs, heads of government made several commitments related to access to essential medicines, technologies, and vaccines for such diseases. 30 years of experience with policies for essential medicines and 10 years of scaling up of HIV treatment have provided the knowledge needed to address barriers to long-term effective treatment and prevention of NCDs. More medicines can be acquired within existing budgets with efficient selection, procurement, and use of generic medicines. Furthermore, low-income and middle-income countries need to increase mobilisation of domestic resources to cater for the many patients with NCDs who do not have access to treatment. Existing initiatives for HIV treatment offer useful lessons that can enhance access to pharmaceutical management of NCDs and improve adherence to long-term treatment of chronic illness; policy makers should also address unacceptable inequities in access to controlled opioid analgesics. In addition to off-patent medicines, governments can promote access to new and future on-patent medicinal products through coherent and equitable health and trade policies, particularly those for intellectual property. Frequent conflicts of interest need to be identified and managed, and indicators and targets for access to NCD medicines should be used to monitor progress. Only with these approaches can a difference be made to the lives of hundreds of millions of current and future patients with NCDs.en_GB
dc.language.isoenen
dc.rightsReproduced on this site with permission of Elsevier Ltd. Please see [url]http://www.thelancet.com/[/url] for further relevant comment.en_GB
dc.titlePromotion of access to essential medicines for Non-Communicable Diseases: Practical implications of the UN Political Declarationen
dc.contributor.departmentDepartment of Global Health, University of Groningen, University Medical Centre, Groningen, Netherlands. h.v.hogerzeil@umcg.nlen_GB
dc.identifier.journalLanceten_GB
All Items in MSF are protected by copyright, with all rights reserved, unless otherwise indicated.